Teladoc (TDOC) Tops Q4 EPS by 5c, guidance misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Teladoc (TDOC) beats FQ4 earnings expectations but guidance falls short; shares slide
February 20, 2024 4:21 PM ESTShares of Teladoc Health (NYSE: TDOC) fell over 11% following the closing bell on Tuesday after the companys FQ4 revenue and FQ1 2024 guidance fell short of expectations.
The healthcare firm reported a loss per share of $0.17 for the quarter, compared to a loss per share of $0.22 expected by analysts. However, revenue came in at $660.53 million, missing the consensus estimate... More
